139 related articles for article (PubMed ID: 33328738)
21. Synchronous multiple primary lung cancers with shared EGFR mutation but differential imaging findings and pathological subtypes: A case report.
Su L; Li Y; Wang T; Wang L; Wang W; Wei X
Respir Med Case Rep; 2020; 31():101244. PubMed ID: 33083221
[TBL] [Abstract][Full Text] [Related]
22. Lung adenocarcinoma in a patient with a cis EGFR L858R-K860I doublet mutation identified using NGS-based profiling test: Negative diagnosis on initial companion test and successful treatment with osimertinib.
Onozawa H; Saito H; Sunami K; Kubo T; Yamamoto N; Kasajima R; Ohtsu T; Hiroshima Y; Kanamori H; Yokose T; Miyagi Y
Thorac Cancer; 2020 Dec; 11(12):3599-3604. PubMed ID: 33034420
[TBL] [Abstract][Full Text] [Related]
23. Identification of a Novel MPRIP-ROS1 Fusion and Clinical Efficacy of Crizotinib in an Advanced Lung Adenocarcinoma Patient: A Case Report.
Shu Y; Li H; Shang H; Chen J; Su X; Le W; Lei Y; Tao L; Zou C; Wu W
Onco Targets Ther; 2020; 13():10387-10391. PubMed ID: 33116618
[TBL] [Abstract][Full Text] [Related]
24. Morphological and genetic heterogeneity in multifocal lung adenocarcinoma: The case of a never-smoker woman.
Bonanno L; Calabrese F; Nardo G; Calistri D; Tebaldi M; Tedaldi G; Polo V; Vuljan S; Favaretto A; Conte P; Amadori A; Rea F; Indraccolo S
Lung Cancer; 2016 Jun; 96():52-5. PubMed ID: 27133750
[TBL] [Abstract][Full Text] [Related]
25. A novel co-existing
Zhu YC; Wang WX; Xu CW; Zhuang W; Song ZB; Du KQ; Chen G; Lv TF; Song Y
Cancer Biol Ther; 2018; 19(12):1097-1101. PubMed ID: 30095326
[TBL] [Abstract][Full Text] [Related]
26. "Evaluation of ROS1 expression and rearrangements in a large cohort of early-stage lung cancer".
Dyrbekk APH; Warsame AA; Suhrke P; Ludahl MO; Moe JO; Eide IJZ; Lund-Iversen M; Brustugun OT
Diagn Pathol; 2023 May; 18(1):70. PubMed ID: 37237384
[TBL] [Abstract][Full Text] [Related]
27. Mutation Profile of Resected
Zhao ZR; Lin YB; Ng CSH; Zhang R; Wu X; Ou Q; Chen W; Zhou WJ; Lin YB; Su XD; Shao YW; Long H
Oncologist; 2019 Oct; 24(10):1368-1374. PubMed ID: 30872465
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness analysis comparing companion diagnostic tests for EGFR, ALK, and ROS1 versus next-generation sequencing (NGS) in advanced adenocarcinoma lung cancer patients.
Schluckebier L; Caetano R; Garay OU; Montenegro GT; Custodio M; Aran V; Gil Ferreira C
BMC Cancer; 2020 Sep; 20(1):875. PubMed ID: 32928143
[TBL] [Abstract][Full Text] [Related]
29. Broad, Hybrid Capture-Based Next-Generation Sequencing Identifies Actionable Genomic Alterations in Lung Adenocarcinomas Otherwise Negative for Such Alterations by Other Genomic Testing Approaches.
Drilon A; Wang L; Arcila ME; Balasubramanian S; Greenbowe JR; Ross JS; Stephens P; Lipson D; Miller VA; Kris MG; Ladanyi M; Rizvi NA
Clin Cancer Res; 2015 Aug; 21(16):3631-9. PubMed ID: 25567908
[TBL] [Abstract][Full Text] [Related]
30. Identifying a wide range of actionable variants using capture-based ultra-deep targeted sequencing in treatment-naive patients with primary lung adenocarcinoma.
Chen L; Chen M; Lin J; Chen X; Yu X; Chen Z; Jin L
Int J Clin Exp Pathol; 2020; 13(3):525-535. PubMed ID: 32269691
[TBL] [Abstract][Full Text] [Related]
31. Differences in driver genes between smoking-related and non-smoking-related lung cancer in the Chinese population.
Gou LY; Niu FY; Wu YL; Zhong WZ
Cancer; 2015 Sep; 121 Suppl 17():3069-79. PubMed ID: 26331813
[TBL] [Abstract][Full Text] [Related]
32. High Discrepancy of Driver Mutations in Patients with NSCLC and Synchronous Multiple Lung Ground-Glass Nodules.
Wu C; Zhao C; Yang Y; He Y; Hou L; Li X; Gao G; Shi J; Ren S; Chu H; Zhou C; Zhang J; Schmid-Bindert G
J Thorac Oncol; 2015 May; 10(5):778-783. PubMed ID: 25629635
[TBL] [Abstract][Full Text] [Related]
33. A case of different
Haratake N; Takenoyama M; Edagawa M; Shimamatsu S; Toyozawa R; Nosaki K; Hirai F; Yamaguchi M; Taguchi K; Seto T; Ichinose Y
J Thorac Dis; 2018 Apr; 10(4):E255-E259. PubMed ID: 29850164
[TBL] [Abstract][Full Text] [Related]
34. Comparable clinical outcomes in patients with HER2-mutant and EGFR-mutant lung adenocarcinomas.
Gow CH; Chang HT; Lim CK; Liu CY; Chen JS; Shih JY
Genes Chromosomes Cancer; 2017 May; 56(5):373-381. PubMed ID: 28063177
[TBL] [Abstract][Full Text] [Related]
35. Analysis of the proliferative activity in lung adenocarcinomas with specific driver mutations.
Kriegsmann M; Harms A; Kazdal D; Fischer S; Stenzinger A; Leichsenring J; Penzel R; Longuespée R; Kriegsmann K; Muley T; Safi S; Warth A
Pathol Res Pract; 2018 Mar; 214(3):408-416. PubMed ID: 29487011
[TBL] [Abstract][Full Text] [Related]
36. The Unique Genetic Mutation Characteristics Based on Large Panel Next-Generation Sequencing (NGS) Detection in Multiple Primary Lung Cancers (MPLC) Patients.
Liang Z; Zeng G; Wan W; Deng B; Chen C; Li F; Lin G; Lin Y; Lin H; Mo G; Miao H
Discov Med; 2023 Apr; 35(175):131-143. PubMed ID: 37188510
[TBL] [Abstract][Full Text] [Related]
37. Analysis of real-word mutations of lung cancer driver genes in five regions of China.
Sun M; Guo Y; Shao G; Duan X; Yang Z; Zhang P; Liu Y; Dong Y; Wang X; Xu Y; Sun C; Ma K
Transl Cancer Res; 2019 Nov; 8(7):2581-2592. PubMed ID: 35117015
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis and treatment of synchronous multiple primary lung cancer - a case report.
Bao Y; Wu J; Zhang J; Yu Y
Onco Targets Ther; 2019; 12():4281-4285. PubMed ID: 31213845
[TBL] [Abstract][Full Text] [Related]
39. Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negative.
Lim SM; Kim EY; Kim HR; Ali SM; Greenbowe JR; Shim HS; Chang H; Lim S; Paik S; Cho BC
Oncotarget; 2016 Apr; 7(17):24172-8. PubMed ID: 26992220
[TBL] [Abstract][Full Text] [Related]
40. Genomic Profiling and Prognostic Value Analysis of Genetic Alterations in Chinese Resected Lung Cancer With Invasive Mucinous Adenocarcinoma.
Cai L; Wang J; Yan J; Zeng J; Zhu L; Liang J; Pan C; Huang X; Jin J; Xu Y; Wang F; Shao Y; Xu Q; Xia G; Xing M; Xu X; Jiang Y
Front Oncol; 2020; 10():603671. PubMed ID: 33505917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
